VIVO
Index
Log in
Search form
Menu
Home
People
Organizations
Research
Events
A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide (Pom)...
Grant
Overview
Affiliation
Identity
View All
Overview
date/time interval
August 7, 2013 - August 6, 2016
awarded by
Celgene Corporation
administered by
UF Health Cancer Center
total award amount
9875.00
direct costs
7900.00
sponsor award ID
CC-4047-MM-007
local award ID
00089456
Affiliation
contributor
Moreb, Jan
Principal Investigator
2013 - 2016
Identity
PeopleSoft Contract Number
00089456